• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 37 of 37
Are U.S. corporate tax inversions a necessary crisis?
FinanceAre U.S. corporate tax inversions a necessary crisis?
By Robert LitanJuly 18, 2014
Canada: A penalty box for pharma innovation
Canada: A penalty box for pharma innovation
By David J. KapposJuly 2, 2014
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
FinanceAstraZeneca fails to win FDA panel backing for cancer treatment
By John KellJune 26, 2014
AstraZeneca shareholders upset by “quick” Pfizer rejection
FinanceAstraZeneca shareholders upset by “quick” Pfizer rejection
By Laura LorenzettiMay 20, 2014
AstraZeneca rejects higher ‘final’ offer from Pfizer
FinanceAstraZeneca rejects higher ‘final’ offer from Pfizer
By Laura LorenzettiMay 19, 2014
Does the AstraZeneca-Pfizer deal make scientific sense?
FeaturesDoes the AstraZeneca-Pfizer deal make scientific sense?
By Jennifer ReingoldMay 15, 2014
Pfizer admits to potential job losses in AstraZeneca takeover
FinancePfizer admits to potential job losses in AstraZeneca takeover
By Laura LorenzettiMay 13, 2014
Pfizer prepares to woo U.K. lawmakers in bid for rival AstraZeneca
FinancePfizer prepares to woo U.K. lawmakers in bid for rival AstraZeneca
By Laura LorenzettiMay 12, 2014
AstraZeneca shares climb in hopes of bigger Pfizer offer
FinanceAstraZeneca shares climb in hopes of bigger Pfizer offer
By Laura LorenzettiMay 9, 2014
Pfizer’s massive tax play for AstraZeneca
FinancePfizer’s massive tax play for AstraZeneca
By Cyrus SanatiApril 29, 2014
Behind Pfizer’s latest upheaval at the top
FeaturesBehind Pfizer’s latest upheaval at the top
By Patricia SellersDecember 17, 2013
Inside Pfizer’s palace coup
Inside Pfizer’s palace coup
By Peter Elkind and Jennifer ReingoldJuly 28, 2011
Pfizer wins big Celebrex ruling
FinancePfizer wins big Celebrex ruling
By Roger ParloffNovember 20, 2007
Supreme Court takes case with big stakes for Vioxx suits
Supreme Court takes case with big stakes for Vioxx suits
By Roger ParloffSeptember 27, 2007
1...
  • 33
  • 34
  • 35
  • 36
  • 37
37
Most Popular
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regretsplaceholder alt text
By Preston ForeApril 27, 2026
AI
‘The cost of compute is far beyond the costs of the employees’: Nvidia executive says right now AI is more expensive than paying human workersplaceholder alt text
By Sasha RogelbergApril 28, 2026
Energy
‘Take the money and run’: Johns Hopkins economist Steve Hanke on why the UAE quit OPECplaceholder alt text
By Shawn TullyApril 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.